Role of atazanavir in the treatment of HIV infection

Atazanavir (ATV) is one of the latest protease inhibitors (PI) approved for the treatment of HIV infection. The drug has a relatively long-life (~7 h) and large inhibitory quotient which allows once daily administration. It is generally well tolerated and the main side effect is hyperbilirubinemia,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivas, Pablo, Morello, Judit, Garrido, Carolina, Rodríguez-Nóvoa, Sonia, Soriano, Vincent
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697529/
https://www.ncbi.nlm.nih.gov/pubmed/19436623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697529/
https://www.ncbi.nlm.nih.gov/pubmed/19436623

Ejemplares similares